Org 5591747638Eddagatan 6 2trResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20180 employees
Revenue 2024
SEK 19K
-91% vs 2023
EBITDA margin
-65.5%
-108% vs 2023
Equity ratio
97.0%
Financial strength
Net profit 2024
SEK -13K
-107% vs 2023
EBITDA — year on yearSEK millionsKey figuresAnnual report 2024
Revenue
SEK 19K
-91%
EBITDA
SEK -13K
-108%
Net profit
SEK -13K
-107%
Total assets
SEK 335K
-46%
Equity
SEK 325K
-33%
Employees
0
—
Company information
Legal name
RG Pharma Development AB
Org number
5591747638
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
10 oktober 2018
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget avser att utföra konsulttjänster inom läkemedels- utveckling eller närliggande område. Vidare kan bolaget vara ägare av verksamhet inom läkemedelsbranschen eller närliggande område.
Contact
Address
Eddagatan 6 2tr
Email
lars.olsson@rgpharma.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.